Researchers from the University of Technology Sydney have developed
a revolutionary technique that enables medical professionals to avoid
invasive biopsy procedures and monitor the efficacy of treatment by
identifying and analysing cancer cells in blood samples.The researchers have created a tool that enables doctors to skip invasive
biopsy operations and to track the effectiveness of treatment by detecting
and analysing cancer cells from blood samples. More than 1,50,000
Australians are diagnosed with cancer each year, making it one of the top
causes of illness and death in the country. Surgery is frequently required
for a conclusive diagnosis in those who have cancer suspicions, especially
when the cancer is in an organ like the liver, colon, or kidney.
a revolutionary technique that enables medical professionals to avoid
invasive biopsy procedures and monitor the efficacy of treatment by
identifying and analysing cancer cells in blood samples.The researchers have created a tool that enables doctors to skip invasive
biopsy operations and to track the effectiveness of treatment by detecting
and analysing cancer cells from blood samples. More than 1,50,000
Australians are diagnosed with cancer each year, making it one of the top
causes of illness and death in the country. Surgery is frequently required
for a conclusive diagnosis in those who have cancer suspicions, especially
when the cancer is in an organ like the liver, colon, or kidney.
Getting a biopsy can cause discomfort to patients, as well as an increased
risk of complications due to surgery and higher costs, but an accurate
cancer diagnosis is vital to effective treatment.
The device uses a unique metabolic signature of cancer to differentiate
tumour cells from normal blood cells. The study, Rapid metabolomic
screening of cancer cells via high-throughput static droplet microfluidics.
